Skip to main content
. 2024 Feb 22;19(2):e0298269. doi: 10.1371/journal.pone.0298269

Fig 3. Concentrations of IgG4 antibodies against PLA2R and its CysR, CTLD1, and CTLD6-7-8 epitopes in patients from the remission and non-remission groups at initial diagnosis.

Fig 3